BioHiTech Global, Inc. provides an environmentally friendly solution for food waste disposal. The Company, through its subsidiaries, BioHiTech America, LLC and BioHiTech Europe Limited, offers its customers various technologies integrating technological, biological and mechanical engineering solutions for the control, reduction and/or reuse of organic waste. It has a distribution license to sell, lease, use, distribute and manufacture the Eco-Safe Digester product. The Eco-Safe Digester is a data-driven, network-based mechanical/biological technology, which transforms food waste into nutrient-neutral water that can be disposed of via conventional sanitary sewer systems. The Eco-Safe Digester may be used by businesses in food service, hospitality, healthcare, government, conference centers, education centers or stadiums. Its Internet enabled system, the BioHiTech Cloud, streams data from the digesters, collects information from system users and integrates business application data.
Industry, Sector and Symbol
Industry Educational services
Sub-IndustryN/A
SectorBusiness Services
Phone845-262-1081
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$3.36 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date11/13/2019 (Estimated)
OptionableNot Optionable
BioHiTech Global (NASDAQ:BHTG) Frequently Asked Questions
What is BioHiTech Global's stock symbol?
BioHiTech Global trades on the NASDAQ under the ticker symbol "BHTG."
How were BioHiTech Global's earnings last quarter?
BioHiTech Global Inc (NASDAQ:BHTG) released its quarterly earnings results on Wednesday, August, 14th. The company reported ($0.15) EPS for the quarter, missing the Zacks' consensus estimate of ($0.05) by $0.10. The firm earned $1.05 million during the quarter. BioHiTech Global had a negative net margin of 230.53% and a negative return on equity of 267.86%. View BioHiTech Global's Earnings History.
When is BioHiTech Global's next earnings date?
What price target have analysts set for BHTG?
2 brokers have issued 1 year price objectives for BioHiTech Global's stock. Their forecasts range from $2.75 to $5.00. On average, they anticipate BioHiTech Global's share price to reach $3.88 in the next year. This suggests a possible upside of 117.7% from the stock's current price. View Analyst Price Targets for BioHiTech Global.
What is the consensus analysts' recommendation for BioHiTech Global?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BioHiTech Global in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for BioHiTech Global.
Has BioHiTech Global been receiving favorable news coverage?
News stories about BHTG stock have been trending very negative recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. BioHiTech Global earned a media sentiment score of -3.2 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for BioHiTech Global.
Who are some of BioHiTech Global's key competitors?
Some companies that are related to BioHiTech Global include Four Seasons Edu (Cayman) (FEDU), Lincoln Educational Services (LINC), ATA (ATAI), Tarena International (TEDU), CIBT Education Group (MBAIF), Wah Fu Education Group (WAFU), ChineseInvestors.com (CIIX), Learning Tree International (LTRE), PCS Edventures! (PCSV), Scientific Learning (SCIL), Legacy Education Alliance (LEAI), National American University Holdngs (NAUH), Creative Learning (CLCN), Blue Calypso (BCYP) and Eos International (EOSI).
What other stocks do shareholders of BioHiTech Global own?
Who are BioHiTech Global's major shareholders?
BioHiTech Global's stock is owned by a number of of retail and institutional investors. Top institutional investors include Gabelli Funds LLC (0.16%). Company insiders that own BioHiTech Global stock include Frank E Celli, James D Chambers and Robert A Joyce. View Institutional Ownership Trends for BioHiTech Global.
Which major investors are buying BioHiTech Global stock?
BHTG stock was acquired by a variety of institutional investors in the last quarter, including Gabelli Funds LLC. Company insiders that have bought BioHiTech Global stock in the last two years include Frank E Celli, James D Chambers and Robert A Joyce. View Insider Buying and Selling for BioHiTech Global.
How do I buy shares of BioHiTech Global?
Shares of BHTG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is BioHiTech Global's stock price today?
One share of BHTG stock can currently be purchased for approximately $1.78.
How big of a company is BioHiTech Global?
What is BioHiTech Global's official website?
How can I contact BioHiTech Global?
BioHiTech Global's mailing address is 80 RED SCHOOLHOUSE ROAD SUITE 101, CHESTNUT RIDGE NY, 10977. The company can be reached via phone at 845-262-1081 or via email at [email protected]
MarketBeat Community Rating for BioHiTech Global (NASDAQ BHTG)
MarketBeat's community ratings are surveys of what our community members think about BioHiTech Global and other stocks. Vote "Outperform" if you believe BHTG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BHTG will underperform the S&P 500 over the long term. You may vote once every thirty days.
